NAMPT and obesity due to melanocortin 4 receptor deficiency: While diabetes alone did not seem to impact tumor NAMPT expression, patients with obesity and/or diabetes had a significantly higher likelihood of having NAMPT- PDAs in comparison to patients without obesity and diabetes (31/71 (43.7%) vs. 24/86 (27.9%), P = 0.04).